Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Haefliger

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Revue Medicale Suisse|October 13, 2017
[Legionellosis]David Haefliger, Christian Chuard
Revue Medicale Suisse|January 20, 2023
[Pharmacotherapy: New drugs and vaccines in 2022]David Haefliger, Françoise Livio
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 27, 2025
Levetiracetam-induced rhabdomyolysis: a rare adverse effect in a patient with status epilepticusLorane Crausaz, Thomas Baumgartner, David Haefliger, et al.
British Journal of Clinical Pharmacology|April 13, 2023
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazoleDavid Haefliger, Catia Marzolini, Frederic Lamoth, et al.
CJC Pediatric and Congenital Heart Disease|March 28, 2024
The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger PatientSarah Grütter, David Haefliger, Grégoire Wuerzner, et al.
Revue Medicale Suisse|January 15, 2025
[Teratovigilance. Antiepileptics during pregnancy and paternal use]Kim Dao, Léonore Diezi, David Haefliger, et al.
Seminars in Dialysis|August 22, 2024
Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case ReportDavid Haefliger, Hassib Chehade, Francoise Livio, et al.
Clinical Pharmacokinetics|November 20, 2025
Population Pharmacokinetics of Propofol in Critically Ill Patients with and Without Extracorporeal Membrane OxygenationStéphane Bertin, David Haefliger, Thomas Mercier, et al.
Frontiers in Pediatrics|August 14, 2025
Pharmacokinetics of levosimendan in critically Ill children on extracorporeal membrane oxygenation: a prospective observational studyStéphane Bertin, David Haefliger, Maria-Helena Perez, et al.
Journal of Clinical Medicine|November 27, 2025
Effects of Extracorporeal Membrane Oxygenation Circuits on Drug Sequestration: A Review of Ex Vivo ExperimentsStéphane Bertin, David Haefliger, Antoine G Schneider, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Revue Medicale Suisse|October 13, 2017
[Legionellosis]David Haefliger, Christian Chuard
Revue Medicale Suisse|January 20, 2023
[Pharmacotherapy: New drugs and vaccines in 2022]David Haefliger, Françoise Livio
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 27, 2025
Levetiracetam-induced rhabdomyolysis: a rare adverse effect in a patient with status epilepticusLorane Crausaz, Thomas Baumgartner, David Haefliger, et al.
British Journal of Clinical Pharmacology|April 13, 2023
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazoleDavid Haefliger, Catia Marzolini, Frederic Lamoth, et al.
CJC Pediatric and Congenital Heart Disease|March 28, 2024
The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger PatientSarah Grütter, David Haefliger, Grégoire Wuerzner, et al.
Revue Medicale Suisse|January 15, 2025
[Teratovigilance. Antiepileptics during pregnancy and paternal use]Kim Dao, Léonore Diezi, David Haefliger, et al.
Seminars in Dialysis|August 22, 2024
Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case ReportDavid Haefliger, Hassib Chehade, Francoise Livio, et al.
Clinical Pharmacokinetics|November 20, 2025
Population Pharmacokinetics of Propofol in Critically Ill Patients with and Without Extracorporeal Membrane OxygenationStéphane Bertin, David Haefliger, Thomas Mercier, et al.
Frontiers in Pediatrics|August 14, 2025
Pharmacokinetics of levosimendan in critically Ill children on extracorporeal membrane oxygenation: a prospective observational studyStéphane Bertin, David Haefliger, Maria-Helena Perez, et al.
Journal of Clinical Medicine|November 27, 2025
Effects of Extracorporeal Membrane Oxygenation Circuits on Drug Sequestration: A Review of Ex Vivo ExperimentsStéphane Bertin, David Haefliger, Antoine G Schneider, et al.
Pageof 2